GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo International PLC (MEX:ENDP) » Definitions » Cyclically Adjusted PS Ratio

Endo International (MEX:ENDP) Cyclically Adjusted PS Ratio : 0.00 (As of Jun. 23, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Endo International Cyclically Adjusted PS Ratio?

As of today (2024-06-23), Endo International's current share price is MXN169.00. Endo International's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was MXN5,364,060.00. Endo International's Cyclically Adjusted PS Ratio for today is 0.00.

The historical rank and industry rank for Endo International's Cyclically Adjusted PS Ratio or its related term are showing as below:

During the past years, Endo International's highest Cyclically Adjusted PS Ratio was 6.65. The lowest was 0.01. And the median was 0.53.

MEX:ENDP's Cyclically Adjusted PS Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.06
* Ranked among companies with meaningful Cyclically Adjusted PS Ratio only.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Endo International's adjusted revenue per share data for the three months ended in Dec. 2023 was MXN35.918. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is MXN5,364,060.00 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Endo International Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Endo International's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endo International Cyclically Adjusted PS Ratio Chart

Endo International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.27 0.43 0.22 - -

Endo International Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Endo International's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Endo International's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Endo International's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Endo International's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Endo International's Cyclically Adjusted PS Ratio falls into.



Endo International Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Endo International's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=169.00/5364060
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Endo International's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Endo International's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=35.918/120.7486*120.7486
=35.918

Current CPI (Dec. 2023) = 120.7486.

Endo International Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 47.975 100.573 57.599
201406 47.065 100.773 56.395
201409 55.247 100.474 66.396
201412 61.411 99.576 74.468
201503 61.569 99.975 74.362
201506 62.240 100.573 74.726
201509 60.214 100.274 72.509
201512 82.367 99.676 99.780
201603 74.612 99.676 90.386
201606 76.417 101.072 91.294
201609 76.758 100.274 92.431
201612 114.850 99.676 139.130
201703 87.604 100.374 105.387
201706 70.935 100.673 85.081
201709 63.952 100.474 76.857
201712 67.596 100.075 81.560
201803 56.938 100.573 68.360
201806 62.740 101.072 74.955
201809 62.213 101.371 74.106
201812 68.823 100.773 82.466
201903 62.221 101.670 73.897
201906 59.415 102.168 70.220
201909 63.550 102.268 75.034
201912 63.602 102.068 75.242
202003 82.557 102.367 97.381
202006 67.917 101.769 80.583
202009 60.966 101.072 72.835
202012 64.494 101.072 77.050
202103 61.486 102.367 72.527
202106 60.898 103.364 71.140
202109 67.962 104.859 78.260
202112 69.302 106.653 78.461
202203 55.529 109.245 61.376
202206 48.697 112.779 52.138
202209 46.335 113.504 49.293
202212 46.071 115.436 48.191
202303 39.486 117.609 40.540
202306 39.857 119.662 40.219
202309 33.447 120.749 33.447
202312 35.918 120.749 35.918

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Endo International  (MEX:ENDP) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Endo International Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Endo International's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Endo International (MEX:ENDP) Business Description

Traded in Other Exchanges
N/A
Address
Simmonscourt Road, Ballsbridge, First Floor, Minerva House, Dublin, IRL, 4
Endo International PLC is a specialty pharmaceutical company with a considerable presence in pain management, urology, orthopedics, endocrinology, bariatrics, and others. It operates in four segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals, and International Pharmaceuticals. The company generates maximum revenue from the Branded Pharmaceuticals segment. Some of its products include XIAFLEX, SUPPRELIN, PERCOCET, TESTOPEL, VASOSTRICT, ADRENALIN, and APLISOL.

Endo International (MEX:ENDP) Headlines

No Headlines